The results of survival analysis revealed significant association of greater BGN expression with poor Overall Survival (OS) in GC patients (Figure 6A, HR = 1.53 (1.09–2.14), p = 0.013), but no significantly association with Disease Specific Survival (DSS) (Figure 6B, HR = 1.43 (0.94–2.19), p = 0.095), and Progress Free Interval (PFI) (Figure 6C, HR = 1.27 (0.89–1.81), p = 0.189). This evidence concerns the gene BGN and gastric cancer.